Telehealth Watch List.

We Haven't Looked at the Telehealth Watch List for a Spell and we Were Very Surprised at the YTD Performance.
Teledoc, Biotech Stock Review

Nothing Quite Like Telehealth. Teledoc (TDOC) Price Targets Raised.

A number of recent price target changes have been made on Teladoc Health, including: Piper Sandler raises target price...
CB Scientific

Philips (PHG) Completes the Acquisition of BioTelemetry, Inc.

Combination of Philips and BioTelemetry results in a global leader in patient care management solutions for the hospital and the home
Hapbee,

Hapbee (HAPB) to Commence Trading on the TSX Venture Exchange.

VANCOUVER, BC, Oct. 28, 2020 /CNW/ - Hapbee Technologies, Inc. (TSXV: HAPB) ("Hapbee" or the "Company"), a wellness technology company developing the...
Biotech Stock Review,

Premier Health (PHGRF) Announces Definitive Agreement to Acquire Livecare.

Livecare is an established leader in the Canadian digital health spaceHave provided over 27,000 telemedicine visitsService over 500 independent active health practitioner...
Biotech Stock Review

Christopher E. Rivera Appointed to the Council of Washington Biotechnology & Biomedical Association

WASHINGTON, DC and SEATTLE, WA – (June 27, 2011) – Today the Washington Biotechnology & Biomedical Association (WBBA) and the Biotechnology Industry...

How CoronaVirus Accelerated the Rise of Telemedicine (CNBC). Telehealth.

16 minute video on how hospitals and primary care practices are using it and what it could mean for the future of...

Huge News at Ehave Inc.(EHVVF), our Favorite Psychedelic.

We just finished compiling the 2021 Psychedelic Investor Guide and reviewed 44 companies - in all shapes and sizes. Excluding Johnson &...
Hapbee

Hapbee’s (HAPB) Device, “Choose How You Feel.”

HAPBEE ANNOUNCES LAUNCH OF A SUBSCRIPTION-BASED WELLBEING WEARABLE, PROVIDING MEMBERS THE ABILITY TO CHOOSE 'HOW THEY FEEL' Proprietary, Research-Backed...
Hapbee

Popular Wellness Wearable Band, Hapbee (HAPB), Launches New Signal “Bedtime.”

Hapbee Completes Development of First New Signal Based on User-feedback and Market Demand; Plans to Launch More Signals this Year

Latest article

Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!

When we added Ardelyx (ARDX) to the Watch List in November of 2022, the market cap near $80 million. Now it's...

GeoVax to Provide Corporate Update on Tuesday May 14, 2024.

Still our favorite biotech microcap, still our favorite management team, and our favorite risk to reward idea with a $4 million market...

NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at the Blink of...

Sanofi (SNY) Announces Partnership - $500 Million Upfront, plus $700 million in Milestones with NovaVax (NVAX). And some investors say Covid is...